Northeast Financial Consultants Inc Amgen Inc Transaction History

Northeast Financial Consultants Inc

$2.25 Billion
Q3 2024

A detailed history of Northeast Financial Consultants Inc transactions in Amgen Inc stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 6,419 shares of AMGN stock, worth $1.82 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,419

Previous 6,386 0.52%

Holding current value

$1.82 Million

Previous $2 Million 3.66%

% of portfolio

0.09%

Previous 0.09%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $10,209 - $11,133	33 Added 0.52%	6,419 $2.07 Million
Q2 2024 Aug 15, 2024	SELL	$262.75 - $319.31 $91,962 - $111,758	-350 Reduced 5.2%	6,386 $2 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $174,765 - $210,964	650 Added 10.68%	6,736 $1.92 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $274,836 - $349,212	1,200 Added 24.56%	6,086 $1.6 Million
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $269,352 - $303,780	-1,200 Reduced 19.72%	4,886 $1.1 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $15,688 - $17,458	-68 Reduced 1.1%	6,086 $1.48 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $14,910 - $16,494	68 Added 1.12%	6,154 $1.49 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $13,523 - $15,476	-68 Reduced 1.1%	6,086 $1.37 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $15,089 - $17,584	68 Added 1.12%	6,154 $1.53 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $41,533 - $46,188	177 Added 3.0%	6,086 $1.55 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $1.07 Million - $1.2 Million	5,909 New	5,909 $1.12 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $768,725 - $897,349	-4,309 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $77,265 - $87,107	-417 Reduced 8.82%	4,309 $893,000
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $18,806 - $21,978	-111 Reduced 2.29%	4,726 $805,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $18,735 - $20,933	111 Added 2.35%	4,837 $841,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $790,612 - $902,666	4,726	4,726 $881,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Account

Northeast Financial Consultants Inc Amgen Inc Transaction History